LATEST NEWS
- Institute News
Joel Martin, Ph.D., MBA, has joined La Jolla Institute for Immunology (LJI) as Managing Director and Chief Business Officer.
- Research News
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
- In the News
New evidence indicates that target cells may play a role in their own destruction.
- Behind the Science
Weiskopf reflects on nearly two years of non-stop COVID-19 research—and a recent honor from her native Austria
- Research News
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
- Behind the Science
"These cells might make a big difference in fighting off viruses"
- Behind the Science
Local high school students bring art and science together for LJI’s Inaugural Art of the Immune System Competition
- In the News
The CDC is reporting every severe breakthrough, but less is known about non-severe cases.
- Behind the Science
"I always wanted to go into medicine, but there aren’t a lot of ways to enter the field as a 15 year old."
- In the News
With the global supply of Covid-19 vaccine still woefully inadequate, vaccine makers are scouring the pharmaceutical landscape for partners to ramp up manufacturing
- Research News
Harnessing the combined power of Vitamin C and TET proteins may give scientists a leg up in treating autoimmune diseases
